After regulatory action by the FDA, the CDC has made efforts to streamline COVID-19 vaccine recommendations and provide greater flexibility for those at higher risk who wish to receive extra doses of the vaccine for added protection.

Today, the CDC’s Advisory Committee on Immunization Practices (ACIP) convened to discuss the updates to COVID-19 vaccine recommendations and their potential implications and implementation. While no formal vote was taken during the meeting, ACIP members expressed their endorsement of the revised recommendations.

• An additional dose of an updated COVID-19 vaccine is recommended for adults aged 65+ and immunocompromised individuals.
• The original monovalent mRNA vaccines are no longer recommended.
• Everyone aged 6+ should receive an updated mRNA vaccine, even if they have completed their (monovalent) primary series.
• Young children should receive multiple doses, depending on their age and previous vaccinations.
• Alternatives such as Novavax or Johnson & Johnson’s Janssen vaccine are available for those who can’t receive mRNA vaccines.

The CDC and  Committee on Immunization Practices (ACIP) will continue to monitor the levels of COVID-19 disease and vaccine effectiveness in the coming months, and anticipate further discussions about potential updates in the fall.

Vaccination is the key to protecting ourselves, our loved ones, and our communities against COVID-19. These updated recommendations provide additional protection for those who need it most and help us move closer to ending this pandemic. So, let’s continue to follow the guidance of health experts and get vaccinated!

Source: https://www.cdc.gov/media/releases/2023/s0419-covid-vaccines.html